Total Abdominal Colectomy is Cost-Effective in Treating Colorectal Cancer in Patients with Genetically Diagnosed Lynch Syndrome
ConclusionsWe conclude that TAC as the primary surgical option for LS patients diagnosed with Stage I-III colon cancer is cost-effective. Further cost-effectiveness study is recommended to include extra-colonic malignancies in LS patients.
Source: The American Journal of Surgery - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Colectomy | Colon Cancer | Colorectal Cancer | Genetics | HNPCC | Lynch Syndrome | Study | Surgery